Sahan, Katherine
Wijesurendra, Rohan
Preiss, David
Mafham, Marion
Sheehan, Mark http://orcid.org/0000-0002-7191-901X
Article History
Received: 31 December 2023
Accepted: 8 July 2024
First Online: 16 August 2024
Declarations
:
: Not applicable.
: Not applicable.
: The authors declare that they have no competing interests. The Nuffield Department of Population Health, University of Oxford, has a staff policy of not accepting honoraria or other payments from the pharmaceutical industry, expect for the reimbursement of costs to participate in scientific meetings. DP and MM are a coinvestigators on the ASCEND PLUS trial (funded by a grant from Novo Nordisk to the University of Oxford), the ORION-4 trial of inclisiran (funded by a grant from Novartis to the University of Oxford). DP is a coinvestigator on the EMPA-KIDNEY trial (funded by a grant from Boehringer Ingelheim to the University of Oxford).